CytoSorbents Corporation (CTSO)

[orangecat]

I'm not certain on the dates, but I think the HemoDefend phase 2 two year SBIR grant wraps up in August and the 1 year SBIR grant for potassium filter wraps up in September or October. This small company is letting the government finance the research of their pipeline products while they focus on commercializing Cytosorb. I call that being fiscally responsible to the shareholders.

As for the XL product, there are a zillion triggers for an out of control immune response leading to cytokine storm, sepsis, etc. Many of them can be controlled with existing treatments, but the cytokine storm becomes the bigger issue than the initial trigger. One of the common triggers, however, is endotoxin from Gram negative bacterial infections. XL will not just treat the unmet medical need of reining in the Cytokine storm, but also the unmet medical need of removing endotoxins from gram negative bacterial infections.